Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) saw some unusual options trading activity on Tuesday. Investors bought 2,036 put options on the company. This represents an increase of 1,655% compared to the typical daily volume of 116 put options.
Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC purchased a new stake in Zynerba Pharmaceuticals in the 2nd quarter worth approximately $210,000. Claraphi Advisory Network LLC lifted its stake in Zynerba Pharmaceuticals by 46.2% in the 2nd quarter. Claraphi Advisory Network LLC now owns 17,503 shares of the company’s stock worth $237,000 after purchasing an additional 5,532 shares in the last quarter. Commonwealth Equity Services LLC purchased a new stake in Zynerba Pharmaceuticals in the 2nd quarter worth approximately $182,000. NEXT Financial Group Inc lifted its stake in Zynerba Pharmaceuticals by